Netflix will acquire Warner Bros. (Credit: Art by Christopher Smith for TheWrap) With Netflix now in the lead position to acquire Warner Bros. Discovery, the streaming industry is looking at a ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video, Ann S. LaCasce, MD, MMSc, highlights preliminary results of a study of a ...

Advances in the automotive industry continue to make cars safer, more efficient, and more reliable than ever. As motor vehicles become more advanced, so do the silicon components that serve as the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Azacitidine-venetoclax showed superior event-free survival and overall response rates compared to traditional induction chemotherapy in AML patients. The study highlighted reduced hospital stays, ...

An Iowa-based entrepreneur is considering building a computer data center in west Eugene and using cooling water from the facility as warm water for a shrimp farm that would be built next door. The ...

In June, Business Insider published an investigation into the data center industry. We wanted to dig into the pace of growth in light of the artificial intelligence boom, as well as the resources the ...

New features aim to tap into unstructured data with smarter analysis by AI — and protect that data from being misused. Users will be able to do more with files stored in Box’s cloud service with new ...

The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

All five patients in a trial with recurrent glioblastoma given a combination of ImmunityBio's (NASDAQ:IBRX) natural killer (NK) cell therapy Anktiva and Novocure's (NASDAQ:NVCR) Optune Gio Tumor ...

Solid phase III efficacy results for Moderna Inc.’s seasonal influenza vaccine, mRNA-1010, may lead the company to resubmit a BLA for a flu/COVID-19 combo shot it has been developing. The top-line ...